IPOLIPID

Ipolipid is nutraceutical combination, effective to correct dyslipidaemia, an alteration of the blood lipid profile, one of the main risk factors in coronary heart disease, which still recognised as one of the main causes of death in the industrialised countries. The fermented red rice extract is titrated in monacolins, statin-like substances capable of inhibiting the activity of specific enzymes involved in the endogenous synthesis of cholesterol, especially of the fraction associated with low-density lipoproteins (LDL). This peculiarity allows Ipolipid to have reduced side effects, in comparison to statins, especially myopathy and hepatic alteration.

Berberine, a substance present in several plants including Berberis aristata, improves the GLUT4 receptors’ sensitivity to insulin, and thus contributes to reducing and stabilising the synthesis of LDL fatty acids in favour of healthy high-density lipoproteins (HDL). Due to this, berberine is particularly effective in case of diabetic patients, whose lipid and glucose profiles are usually altered. The only present limit in the use of berberine is its reduced oral bioavailability.

The combination of berberine with silymarin, contained in the extract of milk thistle, improves its oral bioavailability and therefore increases its clinical efficacy. Clinical studies have indeed proven that this combination actually is more effective than berberine itself. The formula is completed by the presence of Coenzyme Q10 in the form of water-soluble and highly absorbable ubiquinol, whose endogenous production is partially blocked if used by subjects who take statins. Such deficiency causes the side effects of statins and fermented red rice itself.

Ipolipid is indicated as an adjuvant in the treatment of dyslipidemia, associated with high levels of LDL cholesterol.

CONDITIONS OF USE

Take 1 tablet a day, on a full stomach.